Wikiwand AI

Farnesoid X receptor

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

Farnesoid X receptor (FXR), also known as NR1H4 (nuclear receptor subfamily 1, group H, member 4) or bile acid receptor (BAR), is a nuclear receptor that is encoded by the NR1H4 gene in humans.[5][6]

AliasesNR1H4, BAR, FXR, HRR-1, HRR1, RIP14, nuclear receptor subfamily 1 group H member 4, PFIC5
PDBOrtholog search: PDBe RCSB
Quick facts NR1H4, Identifiers ...
NR1H4
Identifiers
AliasesNR1H4, BAR, FXR, HRR-1, HRR1, RIP14, nuclear receptor subfamily 1 group H member 4, PFIC5
External IDsOMIM: 603826; MGI: 1352464; GeneCards: NR1H4
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001163504
NM_001163700
NM_009108
NM_001385711

RefSeq (protein)

NP_001156976
NP_001157172
NP_033134
NP_001372640

Location (UCSC)Chr 12: 100.47 – 100.56 MbChr 10: 89.29 – 89.37 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

FXR is expressed at high levels in the liver and intestine. Chenodeoxycholic acid and other bile acids are natural ligands for FXR. Similar to other nuclear receptors, when activated, FXR translocates to the cell nucleus, forms a dimer (in this case a heterodimer with RXR) and binds to hormone response elements on DNA, which up- or down-regulates the expression of certain genes.[6]

One of the primary functions of FXR activation is the suppression of cholesterol 7 alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid synthesis from cholesterol. FXR does not directly bind to the CYP7A1 promoter. Rather, FXR induces expression of small heterodimer partner (SHP), which then functions to inhibit transcription of the CYP7A1 gene. FXR likewise stimulates the synthesis of fibroblast growth factor 19, which also inhibits expression of CYP7A1 and sterol 12-alpha-hydroxylase (CYP8B1) via fibroblast growth factor receptor 4. In this way, a negative feedback pathway is established in which synthesis of bile acids is inhibited when cellular levels are already high.[7]

The absence of FXR in an FXR-/- mouse model led to increased bile acids in the liver, and the spontaneous development of liver tumors.[8] Reducing the pool of bile acids in the FXR-/- mice by feeding the bile acid sequestering resin cholestyramine reduced the number and size of the malignant lesions.[citation needed]

FXR has also been found to be important in regulation of hepatic triglyceride levels.[9] Specifically, FXR activation suppresses lipogenesis and promotes free fatty acid oxidation by PPARα activation.[9] Studies have also shown the FXR to regulate the expression and activity of epithelial transport proteins involved in fluid homeostasis in the intestine, such as the cystic fibrosis transmembrane conductance regulator (CFTR).[10]

Activation of FXR in diabetic mice reduces plasma glucose and improves insulin sensitivity, whereas inactivation of FXR has the opposite effect.[9]

Gastroesophageal adenocarcinoma

FXR is an important modulator of bile acid homeostasis.[11] Loss of FXR or bile-acid dependent inhibition of FXR in progenitor cells at the gastroesophageal junction drives gastroesophageal adenocarcinoma carcinogenesis.[11]

Interactions

Ligands

A number of ligands for FXR are known, of both natural and synthetic origin.[14][15][16]

Agonists
Antagonists

References

Further reading

Related Articles

Timelines

Top Qs

Fact Checks